A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth

Human hepatocellular carcinoma (HCC) lacks effective curative therapy and there is an urgent need to develop a novel molecular-targeted therapy for HCC. Selective tyrosine kinase inhibitors have shown promise ...

Source: Journal of Experimental and Clinical Cancer Research - March 18, 2019 Category: Cancer & Oncology Authors: Teng Luo, Shou-Guo Zhang, Ling-Fei Zhu, Fei-Xiang Zhang, Wei Li, Ke Zhao, Xiao-Xue Wen, Miao Yu, Yi-Qun Zhan, Hui Chen, Chang-Hui Ge, Hui-Ying Gao, Lin Wang, Xiao-Ming Yang and Chang-Yan Li Tags: Research Source Type: research